Juluca 50 mg/25 mg film-coated tablets
Sponsors
Fundacion Seimc Gesida, Fundacion Seimc Gesida, Instituto De Investigacion Marques De Valdecilla
Conditions
Colonization by methicillin-resistant S. aureus and gut microbiota in users of pre-exposure prophylaxis (PrEP) and people living with HIV (PLHIV) with STIs.Metabolic liver disease in HIV-infected people
Phase 4
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment regimen in HIV-infected patients with metabolic liver disease who maintain undetectable HIV viral load
CompletedCTIS2022-503110-23-00
Start: 2023-05-05End: 2025-07-07Target: 75Updated: 2023-08-28
A multicenter, randomized, controlled, open-label, parallel-group clinical trial in men who have sex with men (MSM) and transgender women with risk sexual behaviors for sexually transmitted infections.
Not yet recruitingCTIS2025-525150-19-01
Target: 392Updated: 2026-08-06